stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

Dr. Martens plc

United Kingdom · LSE: DOCS.L · Market cap: · P/E: · P/S:

Dr. Martens designs and sells its famous boots and shoes to people around the world.

Dr. Martens, or "Docs" to its fans, is a footwear company built on one sturdy, instantly recognizable shoe. Its most famous product is the 1460 boot — the chunky, yellow-stitched, air-cushioned style that started life as a work boot and became a symbol of punk, ska, and pretty much every rebellious youth movement since. The company designs, markets, and sells these boots and shoes to customers across Europe, the Middle East, Africa, the Americas, and Asia-Pacific.

Dr. Martens plc (DOCS.L) Dr. Martens 1460 boots: line art illustration of A single Dr. Martens 1460 lace-up boot shown in profile
1460 boots
The 1460 boot is named after the date Dr. Martens boots were first made.

The business works like this: Dr. Martens designs the shoes and controls its brand tightly, but it doesn't own most of the factories that make them. It leans on a network of third-party manufacturers, mostly in Asia, to actually build the footwear, then sells through its own stores and website, wholesale partners, and distributors. What customers pay for is the look and the story — that distinctive silhouette and the sense that wearing them signals something about who you are. That brand power is why it can charge premium prices for what is, at its core, a rubber-soled boot. The company has had a bumpy ride as a public business. It listed on the London Stock Exchange in 2021, and after a strong start the shares fell hard as demand cooled, especially in the US, where it had grown quickly. America is its biggest market, so any wobble there really hurts. Dr. Martens has been working to fix this by pushing its own direct-to-consumer sales — its stores and website — where it keeps more of the money per pair, and by leaning on its classic styles rather than chasing fashion trends. It has also faced the classic problem of a one-product brand: when the 1460 boot is in fashion, business booms, and when it isn't, there's little else to fall back on.


Competitors range from big sneaker giants like Nike and Adidas to boot makers like Timberland, plus a long tail of cheaper lookalikes. Dr. Martens' edge is authenticity — the real thing carries cultural weight that a copy can't buy. Its vulnerability is the flip side of that: it depends on a single iconic design staying desirable, and on getting its US business back on track.

Saved answer · last researched 14 Nov 2026